Copy Link Print Information

Ro-3306

70 Cited Publications
Customer Review

Based on 70 publication(s) in Google Scholar

Ro-3306 is a potent and selective inhibitor of CDK1, with Kis of 20 nM, 35 nM and 340 nM for CDK1, CDK1/cyclin B1 and CDK2/cyclin E, respectively.

For research use only. We do not sell to patients.

  • Purity: 99.57%
  • CAS No.: 872573-93-8
  • Formula: C18H13N3OS2
  • Molecular Weight:351.45
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Ro-3306 Chemical Structure
    Ro-3306 Chemical Structure
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
  • Experimental Validation Results for Ro-3306
CAS No.: 872573-93-8
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocol
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Ro-3306

More
Customer Validation & Images
RT-PCRBio/Physico-chemical AssayWBCell Imaging/Staining
  • Bio/Physico-chemical Assay
  • WB
  • Cell Imaging/Staining
  • WB
  • RT-PCR
  • RT-PCR
  • Cell Imaging/Staining
  • WB

All CDK Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Ro-3306 Chemical Structure
    Ro-3306 Chemical Structure
    1/16
  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Nov 12;15(1):9529. [Abstract]

    Customer Validation
     Percentage of WT, KO1, and KO2 cells in G1 phase at 0, 0.5, 1, 1.5, 2, and 2.5-hour release after RO-3306 (9 μM) drug treatment for 20 hours; means + s.d. (n = 3), at indicated times, unpaired two-tailed t-test

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 May 26;14(1):3050. [Abstract]

    Customer Validation
     Analyzes of TRABID mRNA and protein levels in HeLa cells treated with 10 μM lovastatin, 2 μg/ml aphidicolin, 10 μM RO-3306, or 3 μM nocodazole for 18 h. Data are mean ± SD, n = 3 independent experiments. P values are determined by one-way ANOVA with Tukey’s post hoc test.

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 May 26;14(1):3050. [Abstract]

    Customer Validation
     HeLa cells transiently expressing V5-TRABID were synchronized at G2 by treatment with 10 μM RO-3306 for 16 h and then released to proceed the cell cycle for 40 min before monitoring the PLA signal with indicated antibodies.

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 May 26;14(1):3050. [Abstract]

    Customer Validation
     Westernblot analysis of TRABID mRNA and protein levels in HeLa cells treated with 10 μM Lovastatin, 2 μg/ml Aphidicolin, 10 μM RO-3306, or 3 μM Nocodazole for 18 h.

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 May 26;14(1):3050. [Abstract]

    Customer Validation
     RT-qPCR analysis of TRABID mRNA and protein levels in HeLa cells treated with 10 μM Lovastatin, 2 μg/ml Aphidicolin, 10 μM RO-3306, or 3 μM Nocodazole for 18 h.

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Cancer Res. 2021 Aug 1;81(15):4079-4093. [Abstract]

    Customer Validation
     Telomere qPCR of NEIL1 digestion in HEP3B cells transfected with NEIL3 siRNA s2, s4, or nontargeting control (siCtrl) for 72 hours. After transfection, cells were synchronized in G1 with 2 mmol/L thymidine, followed by synchronization in G2 with RO-3306 (10 μmol/L, 16 h). Cells were released into mitosis and treated with 2.5 mmol/L KBrO3 for 30 minutes, followed by recovery for 60 minutes.

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Cancer Res. 2021 Aug 1;81(15):4079-4093. [Abstract]

    Customer Validation
     Images of NEIL3 foci (red) and telomere (TTAGGG; green) colocalization by anti-NEIL3 IF and telo-FISH in HEP3B cells. Cells were treated with DMSO, 24-hour vincristine (VCR; 20 nmol/L), 24-hour vincristine (20 nmol/L) + 24-hour Reversine (REV; 0.5 μmol/L) or 24-hour RO-3306 (10 μmol/L).

  • 1/16

    Ro-3306 purchased from MedChemExpress. Usage Cited in: Oncogene. 2018 May;37(19):2601-2614. [Abstract]

    Customer Validation
     HEK-293T cells are treated with the ERK1/2 inhibitor SCH772984 (0.5 µM) and/or the CDK1 inhibitor RO-3306 (9 μM) during the last 18 h of transfection. Cells are lysed after 24 h and western blot is performed with the indicated antibodies. HSP90 is used as a loading control.

  • Ro-3306